Web Access Research Portal

Researcher: Sutherland, BA (Dr Brad Sutherland)

Fields of Research

Central Nervous System
Cellular Nervous System
Signal Transduction
Systems Physiology
Cardiology (incl. Cardiovascular Diseases)
Cell Physiology
Sensory Systems
Basic Pharmacology
Foetal Development and Medicine
Obstetrics and Gynaecology
Exercise Physiology

Research Objectives

Expanding Knowledge in the Medical and Health Sciences
Cardiovascular System and Diseases
Nervous System and Disorders
Neurodegenerative Disorders Related to Ageing
Expanding Knowledge in the Biological Sciences
Diabetes
Child Health
Reproductive System and Disorders
Hearing, Vision, Speech and Their Disorders
Skin and Related Disorders
Endocrine Organs and Diseases (excl. Diabetes)

Career Best Publications

Research Publications

A critical role for astrocytes in hypercapnic vasodilation in brain; Journal of Neuroscience
A systematic review and meta-analysis of randomized controlled trials of endovascular thrombectomy compared with best medical treatment for acute ischemic stroke; International journal of stroke
Alteplase treatment does not increase brain injury after mechanical middle cerebral artery occlusion in the rat; Journal of Cerebral Blood Flow and Metabolism
Animal models of stroke; Reference Module in Neuroscience and Biobehavioral Psychology
Capillary pericytes regulate cerebral blood flow in health and disease; Nature
Cerebral blood flow alteration in neuroprotection following cerebral ischaemia; The Journal of physiology
Cerebral heme oxygenase 1 and 2 spatial distribution is modulated following injury from hypoxia-ischemia and middle cerebral artery occlusion in rats; Neuroscience Research
Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoid CB2 receptor in the brain; Neuroscience letters
Characterization of a rat hypoxia-ischemia model where duration of hypoxia is determined by seizure activity; Journal of Neuroscience Methods
Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke; CNS & neurological disorders drug targets
Differential effects of paracrine factors on the survival of cells of the neurovascular unit during oxygen glucose deprivation; International journal of stroke
Importance of preclinical research in the development of neuroprotective strategies for ischemic stroke; JAMA neurology
Inhalation gases or gaseous mediators as neuroprotectants for cerebral ischaemia; Current drug targets
Interview with Helen Shield
Keynote speaker: pre-clinical research the potential therapeutic opportunities for various gases including oxygen; British Hyperbaric Association Annual Meeting
Laser Doppler Flowmetry to Measure Changes in Cerebral Blood Flow; Cerebral Angiogenesis Methods and Protocols
Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration; Journal of Nutritional Biochemistry
Melatonin treatment following stroke induction modulates L-arginine metabolism; Journal of Pineal Research
Multi-modal assessment of neurovascular coupling during cerebral ischaemia and reperfusion using remote middle cerebral artery occlusion; Journal of Cerebral Blood Flow and Metabolism
Neuroprotection for ischaemic stroke: Translation from the bench to the bedside; International Journal of Stroke
Neuroprotection for Stroke: Current Status and Future Perspectives; International journal of molecular sciences
Neuroprotective effects of (–)-epigallocatechin gallate after hypoxia-ischemia-induced brain damage: novel mechanisms of action; The FASEB Journal
Novel method to study pericyte contractility and responses to ischaemia in vitro using electrical impedance; Journal of Cerebral Blood Flow and Metabolism
Reply: Intravenous thrombolysis for ischaemic strokes: a call for reappraisal; Brain
Reply: Thrombolysis in acute ischaemic stroke; Brain
Science in the Pub, Brain edition: Neuropathy, Stroke and Alzheimer's Disease
Targeting Pericytes and the Microcirculation for Ischemic Stroke Therapy; Neuroprotective Therapy for Stroke and Ischemic Disease
Targeting Pericytes and the Microcirculation for Ischemic Stroke Therapy; Neuroprotective Therapy for Stroke and Ischemic Disease
The biology and pathology of hypoxia-ischemia: an update; Archivum immunologiae et therapiae experimentalis
The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity; Journal of Cerebral Blood Flow and Metabolism
The exact science of stroke thrombolysis and the quiet art of patient selection; Brain
The future of stroke therapy must not be mired by past arguments; The Lancet
The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments); Journal of Cerebral Blood Flow and Metabolism
The life of Bo K. Siesjö, MD, PhD, 1930–2013; International Journal of Stroke
The role of antioxidants in models of inflammation: emphasis on L-arginine and arachidonic acid metabolism; Inflammopharmacology
The role of the endoplasmic reticulum stress response following cerebral ischemia; International journal of stroke
The transient intraluminal filament middle cerebral artery occlusion model as a model of endovascular thrombectomy in stroke; Journal of cerebral blood flow and metabolism
Thrombolytic Agents for Acute Ischaemic Stroke Treatment: The Past, Present and Future; CNS & neurological disorders drug targets
Tin Protoporphyrin Provides Protection Following Cerebral Hypoxia-Ischemia: Involvement of Alternative Pathways; Journal of neuroscience research

Research Projects

Blood vessels squeezed to death by pericytes: a new therapeutic target for ischaemic stroke; Rebecca L Cooper Medical Research Foundation (RLCMRF)
Blood-brain barrier energy dysfunction: the unifying cause of fatigue; The Mason Foundation (ANZCT-Mason Fdn)
Can anti-diabetic agents improve blood flow and outcome following stroke in type 2 diabetes?; Royal Hobart Hospital Research Foundation (RHHRF)
Can idebenone be used to reduce severity of stroke?; Royal Hobart Hospital Research Foundation (RHHRF)
In pursuit of an innovative experimental model of vascular dementia-a pilot study; University of Tasmania (UTAS)
Investigating ferroptosis as a novel mechanism of oligodendrocyte death.; Brain Foundation (BrainF)
Paving the way for future stroke drug development: creating a reproducible, humanised model of stroke; Royal Hobart Hospital Research Foundation (RHHRF)
Pericyte dysfunction limiting energy supply in Alzheimer's disease; National Health & Medical Research Council (NHMRC)
Squeezed to death by pericytes: a new target for ischaemic stroke treatment; University of Tasmania (UTAS)
The pathological effects of Alzheimer's disease on axons; Dementia Australia Research Foundation Ltd (DARF)
The Peri-Peri project: the role of pericytes in placental function and perinatal outcome; Royal Hobart Hospital Research Foundation (RHHRF)

Research Candidate Supervision